Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03374488
Brief Title: Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma

First Submitted : December 11, 2017
First Submitted that Met QC Criteria : December 11, 2017
First Posted : December 15, 2017

Results First Submitted : July 26, 2019
Results First Submitted that Met QC Criteria : August 14, 2019
Results First Posted : August 26, 2019 (Estimate)

Last Update Submitted that Met QC Criteria : August 14, 2019
Last Update Posted : August 26, 2019 (Estimate)